The standard semaglutide dose for weight loss starts at 0.25 mg once weekly. The dose increases every 4 weeks to a maintenance level of 2.4 mg. In March 2026, the FDA approved a higher 7.2 mg dose called Wegovy HD for patients who need more weight loss. The right schedule keeps side effects manageable and results steady — whether you use injections, oral Wegovy pills, or Rybelsus.
Key takeaways
- Semaglutide titration starts at 0.25 mg weekly and increases every 4 weeks.
- The standard maintenance dose for Wegovy injection is 2.4 mg weekly.
- The FDA also approves 1.7 mg weekly as a maintenance dose for patients who cannot tolerate 2.4 mg.
- In March 2026, the FDA approved Wegovy HD (semaglutide 7.2 mg) for additional weight loss.
- Oral Wegovy starts at 1.5 mg daily and reaches 25 mg by day 91.
- Rybelsus, the oral semaglutide for type 2 diabetes, tops out at 14 mg daily.
- Average weight loss ranges from 14.9% at 2.4 mg to 20.7% at 7.2 mg.
- Skipping dose steps raises the risk of nausea, vomiting, and dehydration.
What is semaglutide and how does it work?
Semaglutide is a GLP-1 receptor agonist made by Novo Nordisk. It mimics a natural hormone called glucagon-like peptide-1. This hormone tells the brain you feel full and slows how fast the stomach empties. The result is lower appetite, smaller portions, and steady weight loss over months.
Semaglutide comes in four FDA-approved brand-name products:
- Wegovy (weekly injection, 1.7 mg / 2.4 mg / 7.2 mg) — chronic weight management.
- Wegovy pills (oral, 25 mg daily) — chronic weight management, approved December 2025.
- Ozempic (weekly injection, up to 2.0 mg) — type 2 diabetes.
- Rybelsus (oral, up to 14 mg daily) — type 2 diabetes.
Semaglutide dosing chart for 2026
The Wegovy injection titration schedule follows a steady step-up every 4 weeks. Most patients reach the 2.4 mg maintenance dose around week 17. The chart below shows the full escalation, including the new 7.2 mg Wegovy HD step approved in March 2026.
Figure 1. Wegovy injection dosing schedule, weeks 1 through 21+.
| Weeks | Weekly dose | Phase |
|---|---|---|
| 1–4 | 0.25 mg | Starting dose (builds tolerance) |
| 5–8 | 0.5 mg | First step-up |
| 9–12 | 1.0 mg | Mid-titration |
| 13–16 | 1.7 mg | Near-target dose (FDA-approved maintenance option) |
| 17+ | 2.4 mg | Standard maintenance dose |
| 21+ | 7.2 mg | Wegovy HD (optional, since March 2026) |
The 7.2 mg step only applies after at least 4 weeks at 2.4 mg. A clinician must confirm that more weight reduction is medically needed before moving up.
What is the starting dose of semaglutide for weight loss?
The starting semaglutide dose for weight loss is 0.25 mg once weekly for the first 4 weeks. This low dose lets your body adjust and reduces the risk of nausea or vomiting. The 0.25 mg dose is not therapeutic on its own — it only builds tolerance.
For oral Wegovy, the starting dose is 1.5 mg once daily for 30 days. For Rybelsus, the starting dose is 3 mg daily for the same period. Never skip ahead to a higher dose without medical guidance.
What is the average semaglutide dose for weight loss?
The average semaglutide dose patients reach for weight loss is 2.4 mg weekly. About 70% of patients on Wegovy tolerate the full 2.4 mg maintenance dose. The remaining patients usually stay at 1.7 mg long-term because of gastrointestinal side effects.
In a 2024 real-world study of 40 adults, the average maintenance dose was 1.0 mg in 16 cases and 2.0 mg in 9 cases. Both groups lost a similar amount of weight — about 13% of body weight over 6 months. This shows that lower doses can still work well for many patients.
For oral semaglutide, the average maintenance dose splits by product. Wegovy pill patients usually settle at the full 25 mg daily dose for weight loss. Rybelsus patients with type 2 diabetes most often stay at 7 mg or 14 mg daily.
What is the maintenance dose of semaglutide?
The maintenance dose is the steady weekly dose you take after titration ends. For Wegovy, the FDA approves three maintenance options:
- 2.4 mg weekly — the standard maintenance dose used in the STEP 1 and STEP 5 trials.
- 1.7 mg weekly — an FDA-approved alternative if 2.4 mg is not tolerated.
- 7.2 mg weekly (Wegovy HD) — for adults who tolerated 2.4 mg for at least 4 weeks and need more weight loss.
Maintenance treatment is long-term. The STEP 1 trial extension showed patients regained about two-thirds of lost weight within one year of stopping semaglutide. Most patients need to stay on a maintenance dose to keep their results.
Your provider will check tolerance, weight loss progress, and side effects every 3 to 6 months. They may keep you at 1.7 mg if it works, or move you to 7.2 mg if 2.4 mg stops producing results.
What is the maximum dose of semaglutide for weight loss?
The maximum semaglutide dose depends on the brand and the FDA-approved use:
- Wegovy injection: 2.4 mg or 7.2 mg weekly (Wegovy HD, approved March 19, 2026).
- Oral Wegovy pill: 25 mg once daily.
- Ozempic injection: 2.0 mg weekly (type 2 diabetes).
- Rybelsus tablet: 14 mg once daily (type 2 diabetes).
Wegovy HD delivered 20.7% mean weight loss over 72 weeks in the STEP UP trial. About 31.2% of participants lost 25% or more of their starting weight. Novo Nordisk launched the 7.2 mg dose in the US in April 2026.
Not every patient needs the maximum dose. The provider sets the target based on tolerance, weight goal, and side effect profile.
Semaglutide product dosing comparison
The four semaglutide products share the same active ingredient but follow different dose ladders. The table below summarizes each schedule.
| Product | Form | Starting dose | Maintenance dose | Frequency |
|---|---|---|---|---|
| Wegovy | Injection | 0.25 mg | 1.7 / 2.4 / 7.2 mg | Weekly |
| Wegovy pill | Oral tablet | 1.5 mg | 25 mg | Daily |
| Ozempic | Injection | 0.25 mg | 1.0 / 2.0 mg | Weekly |
| Rybelsus | Oral tablet | 3 mg | 7 / 14 mg | Daily |
Wegovy and Wegovy HD are the only forms FDA-approved for weight loss as injections. Wegovy pill is the only oral form approved for weight management. Ozempic and Rybelsus are approved for type 2 diabetes only.
How does semaglutide dose titration work?
Titration is the gradual increase of medication every 4 weeks. The schedule gives your stomach and appetite signals time to adapt to each new level. Most patients stay 4 weeks at each step before moving up.
Slow titration helps in three ways:
- It reduces nausea, vomiting, and diarrhea.
- It keeps weight loss steady and sustainable.
- It lowers the risk of dehydration and pancreatitis.
If side effects spike, your provider may keep you at the current dose longer. Some patients also stop at 1.7 mg if it controls weight well enough.
How much weight loss can you expect at each dose?
Average weight loss depends on the dose, treatment length, and whether the patient also has type 2 diabetes. The table below shows results from the main semaglutide trials.
| Dose | Trial | Duration | Average weight loss |
|---|---|---|---|
| 1.0 mg weekly (injection) | STEP 2 | 68 weeks | ~7.0% (adults with type 2 diabetes) |
| 2.4 mg weekly (injection) | STEP 1 | 68 weeks | 14.9% |
| 2.4 mg weekly (injection) | STEP 5 | 104 weeks | 15.2% |
| 7.2 mg weekly (injection) | STEP UP | 72 weeks | 20.7% |
| 25 mg daily (oral) | OASIS 4 | 64 weeks | 13.6%–16.6% |
Most patients begin to see noticeable weight loss within 4–8 weeks. Bigger results come at the 2.4 mg and 7.2 mg maintenance levels. Patients with type 2 diabetes typically lose less weight than patients without it, at the same dose.
How do you take oral Wegovy (semaglutide pills)?
Oral Wegovy must be taken once daily, first thing in the morning, on an empty stomach. Use no more than 4 oz of plain water. Wait at least 30 minutes before eating, drinking anything else, or taking other pills.
The Novo Nordisk titration runs:
- 1.5 mg daily on days 1–30.
- 4 mg daily on days 31–60.
- 9 mg daily on days 61–90.
- 25 mg daily from day 91 (maintenance dose).
The strict empty-stomach rule is required because food cuts absorption sharply. The same rule applies to Rybelsus.
Switching between semaglutide forms or doses
Patients sometimes need to switch the injection for the pill, move to Wegovy HD, or step down a dose. Always coordinate any change with a prescriber. The most common transitions are:
- Wegovy 2.4 mg → Wegovy HD 7.2 mg: Continue weekly injections. The dose increases after at least 4 weeks at 2.4 mg, if more weight loss is clinically needed.
- Wegovy injection → Wegovy pill: Stop the injection. Start oral Wegovy 25 mg one week later for patients on the 2.4 mg dose. Lower doses may need a different starting tablet.
- Wegovy pill → Wegovy injection: Stop the pill. Start the injection at a dose set by the prescriber, based on your current oral dose.
- Step-down within Wegovy: If side effects appear at 2.4 mg, your provider may lower the dose to 1.7 mg. This stays an FDA-approved maintenance level.
What happens if you miss a semaglutide dose?
If your next Wegovy injection is more than 2 days away, take the missed dose as soon as you remember. If less than 2 days away, skip the dose and resume your regular schedule. For Ozempic, the window is 5 days.
For oral Wegovy or Rybelsus, never double up. Skip the missed tablet and continue the next morning. If you miss two or more weekly injections in a row, call your provider before resuming.
Side effects at each dose
Gastrointestinal side effects are common during titration. They usually peak after a dose increase and ease within 1–2 weeks. The most reported reactions across all doses are:
- Nausea, vomiting, diarrhea, constipation.
- Stomach pain, bloating, belching.
- Decreased appetite, mild fatigue.
The new 7.2 mg dose added one notable signal: about 22% of patients reported dysesthesia (tingling or altered skin sensation). Most cases were mild and resolved on their own. About 3% of STEP UP participants stopped treatment because of side effects.
Semaglutide carries a boxed warning for thyroid C-cell tumors. See the full FDA Wegovy label for the complete safety profile.
Conclusion
Safe semaglutide dosing starts low and increases on a fixed schedule. Most patients reach the 2.4 mg maintenance dose around week 17. The FDA-approved alternatives — 1.7 mg or Wegovy HD 7.2 mg — give providers more flexibility to match dose to tolerance and weight goals.
The best semaglutide treatment plan fits your medical history, weight goals, and daily routine. A licensed prescriber can build that plan with you. Schedule a free consultation with Heally to start safely.
FAQ
What is the starting dose of semaglutide for weight loss?
The starting dose is 0.25 mg injected once weekly for 4 weeks. This low dose builds tolerance and lowers early side effects. It does not produce meaningful weight loss on its own.
What is the average semaglutide dose?
The average maintenance dose for weight loss is 2.4 mg weekly. About 70% of patients tolerate this dose. The remaining 30% stay at 1.7 mg long-term, which is also FDA-approved.
What is the maximum semaglutide dose approved by the FDA?
For weight loss, the FDA approved Wegovy HD (semaglutide 7.2 mg weekly) in March 2026. The previous ceiling was 2.4 mg. For type 2 diabetes, Ozempic tops out at 2.0 mg weekly.
How long does it take to reach the maintenance dose?
Most patients reach the 2.4 mg maintenance dose around week 17, after four titration steps. Wegovy HD adds at least another 4 weeks at 7.2 mg. Some patients need a slower ramp if side effects appear.
Can I take semaglutide at any time of day?
Wegovy injections can be taken at any time, with or without food, on the same day each week. Oral Wegovy and Rybelsus must be taken in the morning on an empty stomach.
What happens if I skip a semaglutide dose?
For Wegovy injections, take the dose within 2 days, or skip it. For Ozempic, the window is 5 days. For oral semaglutide, skip the missed dose and continue the next morning — never double up.
Is the new Wegovy HD 7.2 mg dose for everyone?
No. Wegovy HD is for adults who have tolerated 2.4 mg for at least 4 weeks and still need more weight loss. A healthcare provider must confirm the higher dose is clinically appropriate.
Do I have to stay on semaglutide forever?
Most patients need long-term treatment to keep their weight loss. Trial data show patients regain about two-thirds of lost weight within one year of stopping semaglutide. Your provider can help you plan a maintenance strategy.
Sources
- FDA — Wegovy (semaglutide) prescribing information, 2025
- Novo Nordisk — Wegovy HD (semaglutide 7.2 mg) FDA approval announcement, March 2026
- New England Journal of Medicine — STEP 1 trial: once-weekly semaglutide in adults with overweight or obesity
- Nature Medicine — STEP 5 trial: two-year effects of semaglutide in adults with overweight or obesity
- NCBI StatPearls — Semaglutide pharmacology and clinical use
- Novo Nordisk — Wegovy oral tablet (semaglutide 25 mg) FDA approval, December 2025
- Drugs.com — Semaglutide dosage guide
Medical disclaimer
This article is for informational purposes only and does not replace medical advice. Always consult a licensed healthcare provider before starting, stopping, or changing a semaglutide prescription. Individual results vary.
